Daily as of 2 Nov 16:00 ET
- Price
- below both $18.86 vs 50 $20.52 / 200 $21.24
- Projection
- No cross projected
- Test
- Cross test window open, no test bar yet
- Last cross
- 💀Death cross 26 Oct 2026 · projected 28 bars out
DNLI | Denali TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$18.86
-$0.08 (-0.42%)
Denali Therapeutics (DNLI) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits below the 50 and the 200; on the 4-hour it is between the two. On the weekly a golden cross is projected within 10 bars.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $18.94 vs 50 $20.52 / 200 $21.05
- Projection
- 🟨Golden cross projected in 6 bars
- Test
- No active test
- Last cross
- 💀Death cross week of 5 Sep 2022 · projected 28 bars out · tested 3 bars
4-hour as of 3 Nov 16:00 ET
- Price
- between the two $19.45 vs 50 $19.00 / 200 $22.39
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 24 Sep 2026 · projected 30 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 26 Oct 2026 | 💀Death steep | daily | 28 bars out | Active Cross Test |
| 24 Sep 2026 | 💀Death | 4-hour | 30 bars out | Not tested |
| 18 Jun 2026 | 🟨Golden | 4-hour | 20 bars out | Not tested |
| 19 May 2026 | 💀Death | 4-hour | 17 bars out | 2 bar cross test |
| 17 Nov 2025 | 🟨Golden flat | daily | 24 bars out | Not tested |
About DNLI
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$30.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandmid